DURAZOME

SUSTAINED RELEASE PHARMACEUTICALS FOR USE IN THE TREATMENT OF PHYSIOLOGIC DISEASES, BEHAVIORAL DISORDERS, CARDIAC DISORDERS, METABOLIC DISEASES, NEOPLASIA, LAMENESS, ENDO AND ECT-PARASITIC INFECTIONS, AND INFECTIOUS DISEASE CAUSED BY VIRAL, BACTERIAL, PROTOZOAL, PRION, MYCOPLASMA, AND FUNGI ORGANISMS IN DIARY AND BEEF CATTLE, CHICKENS, TURKEYS, DOGS, CATS, SHEEP, HORSES, MULES, DONKEYS, HOGS, DOMESTIC AND EXOTIC BIRDS, AND FARM-RAISED GAME ANIMALS